Prices delayed ≤15 min
AI Analysis Summary
UnitedHealth Group Incorporated at a Glance: What the Business Does UnitedHealth Group Incorporated (UNH) is a prominent player in the U.S. healthcare sector, operating primarily through four key segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The company provides a wide range of health benefit plans and services tailored for diverse clients, including national employers, public sector entities, and individuals, particularly those aged 50 and older. UNH's competitive advantages stem from its extensive network, innovative healthcare solutions, and robust data analytics capabilities, enabling it to deliver personalized care and manage costs effectively. With a workforce of approximately 400,000 employees and its headquarters in Eden Prairie, Minnesota, UnitedHealth Group has established a formidable market position within the medical healthcare plans industry. Its unique integration of technology and health services positions it as a leader in improving health outcomes while managing healthcare expenses. Breaking Down UNH's Financials: Revenue, Margins & EPS UnitedHealth Group's financial performance has shown a solid upward trajectory, with revenue reaching $447.57 billion in the latest fiscal year, up 11.8% year-over-year from $400.28 billion. The company's gross profit stands at $82.92 billion, translating to a gross margin of 18.5%. However, the operating income of $18.96 billion reflects an operating margin of only 4.2%, indicating challenges in managing operational costs. Net income for the year was reported at $12.06 billion, resulting in a net margin of 2.7%. The earnings per share (EPS) for UNH is $13.23, which, while substantial, has been impacted by a decline of 15.4% year-over-year. The EBITDA of $23.06 billion further illustrates the company’s substantial earnings potential, despite facing slight pressures on net income and EPS growth. UNH Balance Sheet Check: Debt, Cash & Liquidity Examining UnitedHealth Group's balance sheet reveals a total asset value of $309.58 billion against total liabilities of $207.88 billion, resulting in shareholders' equity of $94.11 billion. The company carries a total debt of $78.39 billion, while it holds $24.36 billion in cash, leading to a net debt position of $54.02 billion. While the current ratio is at 0.79, suggesting a tighter liquidity position, the overall debt levels are manageable considering the company's substantial revenue base. The absence of a defined debt-to-equity ratio, however, makes it challenging to assess leverage directly. Overall, UNH's balance sheet appears robust, but investors should remain vigilant regarding its debt levels in relation to cash flow. Where Does UNH's Cash Go? A Capital Allocation Review UnitedHealth Group demonstrates a healthy operating cash flow, which stands at $19.70 billion. This strong cash generation supports a free cash flow of $16.07 billion, although it has experienced a decline of 22.4% year-over-year. The company allocated approximately $5.54 billion towards stock buybacks, reflecting a commitment to returning value to shareholders. However, there are no dividends paid, which may influence income-focused investors. The capital expenditure of $3.62 billion indicates that UNH is also investing in future growth through infrastructure and technology. Despite the recent drop in free cash flow growth, the company’s ability to generate significant cash remains a positive indicator for its operational efficiency. UNH Valuation: Expensive, Cheap, or Fairly Priced? Currently, UnitedHealth Group's stock trades at a price of $331.83, with a market capitalization of $300.58 billion. The price-to-book (P/B) ratio is 3.19, while the price-to-sales (P/S) ratio is relatively low at 0.67, suggesting that the stock may be undervalued compared to its revenue generation capacity. With no current P/E or PEG ratios available, it is difficult to gauge the stock's valuation in the context of earnings growth expectations. However, the dividend yield of 0.70% indicates a modest return on investment for shareholders. Overall, when compared to its peers in the healthcare sector, UNH’s valuation metrics suggest that the stock could be fairly priced, reflecting market expectations of steady growth. Catalysts Ahead: UNH's Growth Outlook & Analyst Estimates Looking ahead, UnitedHealth Group is poised for growth driven by several factors, including an aging population, increased healthcare needs, and ongoing expansion in its Optum segments. While specific analyst estimates are currently unavailable, the company’s recent revenue growth trend suggests positive momentum. The growing demand for integrated healthcare solutions and technology-driven services positions UNH to capitalize on market opportunities. Furthermore, the company's ability to leverage data analytics for improved patient outcomes could enhance its market share. Investors should monitor developments in regulatory environments and healthcare policy, as these could serve as additional catalysts for growth. UNH Investment Risks Worth Knowing About While UnitedHealth Group presents a compelling investment proposition, several risks warrant attention. The company's substantial debt burden of $78.39 billion poses a risk, particularly if interest rates rise or if operational challenges persist. Margin compression is another concern, as demonstrated by the declining net income margin of 2.7%. Competitive threats from other healthcare providers and emerging technologies could also impact market share and profitability. Additionally, regulatory risks, especially in the evolving healthcare landscape, could affect operational dynamics. Notably, UNH's beta of 0.43 indicates lower volatility compared to the broader market, which may appeal to conservative investors, but macroeconomic sensitivity remains a consideration. 2026 Outlook: Is UnitedHealth Group Incorporated Stock Worth Owning? In conclusion, UnitedHealth Group Incorporated (UNH) presents a balanced investment opportunity characterized by solid revenue growth, a robust balance sheet, and a strategic focus on expanding its healthcare offerings. With a current price of $331.83, the stock appears to be fairly valued, although ongoing monitoring of its financial performance and market conditions is essential. Investors seeking growth exposure in the healthcare sector may find UNH attractive, while its modest dividend yield might appeal to some income-focused investors. However, potential buyers should remain aware of the risks associated with debt levels, margin pressures, and competitive dynamics in the industry. As the company navigates these challenges, it will be crucial for investors to keep a close eye on its financial metrics and market position as 2026 approaches.
About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provi
Frequently Asked Questions about UNH
UnitedHealth Group Incorporated (UNH): what does the company actually do?
UnitedHealth Group operates as a comprehensive health care company in the U.S., divided into four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. It provides a range of consumer-oriented health benefit plans and services, catering to both individuals and national employers.
Is UNH worth adding to a portfolio in 2026?
With a revenue of $447.57 billion and a solid growth rate of 11.8%, UNH demonstrates potential for continued expansion. However, investors should weigh this against its current price of $331.83 and the absence of a P/E ratio, which complicates direct valuation comparisons.
What are UnitedHealth Group Incorporated's market cap and current trading price?
Currently, UNH is trading at $331.83, which positions it within a market capitalization of approximately $300.58 billion. This places it significantly below its 52-week high of $606.36 and above its low of $234.60, suggesting a notable price fluctuation over the past year.
Is UNH a dividend-paying stock?
Yes, UnitedHealth Group does distribute a dividend, currently set at $2.32 per share, translating to a yield of 0.70%. This could appeal to investors looking for income, although the yield is modest compared to some other stocks.
How does UnitedHealth Group Incorporated stack up on profitability?
UnitedHealth Group reported a net income of $12.06 billion, resulting in a net margin of 2.7%. While specific ROE data isn't available, the company also boasts a free cash flow of $16.07 billion, indicating strong cash generation capabilities.
Is UNH trading at a reasonable P/E multiple?
Currently, UNH does not have a P/E ratio available, making it challenging to assess its valuation in comparison to peers in the healthcare sector. This absence of data could be a point of concern for investors seeking traditional valuation metrics.
Is UnitedHealth Group Incorporated carrying a lot of debt?
UnitedHealth's debt-to-equity ratio is not applicable, suggesting a potentially low debt level or a lack of reported debt data. The company maintains a current ratio of 0.79, which may indicate some liquidity concerns, but it also boasts a robust free cash flow.
What's the 52-week high and low for UNH?
The 52-week high for UNH is $606.36, while its low is $234.60. The current trading price of $331.83 is situated between these extremes, and it is also near the 50-day moving average of $335.41, indicating some stability in its recent performance.
Does UNH behave more like a growth stock or a value stock?
With a revenue growth rate of 11.8%, UNH leans more towards a growth stock profile. However, the absence of EPS data makes it difficult to fully assess its growth trajectory in relation to traditional value metrics.
What's the biggest risk factor for UNH investors?
One significant risk factor for UNH investors is its beta of 0.43, reflecting lower volatility compared to the market. However, competition in the healthcare sector and potential regulatory changes could pose additional challenges.